BCL2 and cancer: Interestingly, an earlier study by Pandey et al. showed that ER and mitochondria-targeted NPs could potentially inhibit the function of anti-apoptotic proteins like Bcl2 facilitating cell death, indicating the importance and putative synergy between these organelles, which can be utilized in the future for cancer therapy [40].